
Boston Scientific's (BSX) New Buyout to Aid Clot Management
Published on September 22, 2021
The acquisition of Devoro Medical by Boston Scientific (BSX) is expected to advance the company's core emphasis on clot management.

The acquisition of Devoro Medical by Boston Scientific (BSX) is expected to advance the company's core emphasis on clot management.